ArticleThe Indian journal of medical research2024

Safety analysis of all active risk evaluation & mitigation strategy for U.S. FDA approved drugs - An Indian perspective.

Miteshkumar Rajaram Maurya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.